No abstract available.
Carcinoembryonic Antigen* ; Citalopram*

No abstract available.
Carcinoembryonic Antigen* ; Citalopram*

No abstract available.
Carcinoembryonic Antigen ; Colorectal Neoplasms

No abstract available.
Carcinoembryonic Antigen ; Colorectal Neoplasms

Background: Human carcinoembryonic antigen (CEA) is widely used as tumor marker. Striking similarities have been reported between process of tumor genesis and atherosclerotic diseases. CEA has been reported as a useful biomarker for diagnosis of acute coronary syndrome whose main pathogenesis mechanism is rupture of atherosclerotic plaque. Although same pathogenic mechanism leads to ischemic stroke, the role of CEA in stroke has not been studied. This study was aimed at evaluating role of CEA as diagnostic marker for acute atherosclerotic ischemic stroke. Methods: Sixty male subjects between 40 to 60 years of age were divided into 2 groups with 30 subjects each: Group A (ischemic stroke) and Group B (age and sex matched healthy controls). Exclusion criteria for Group A included diabetes mellitus, heavy smoking, recent cerebrovascular or myocardial events. The blood sample was taken not later than 24 hours of onset of stroke in Group A. In Group B, the blood samples were drawn at the time of enrollment in the study. CEA levels were estimated using double sandwich ELISA method. Results: The mean (SE) serum CEA levels in healthy controls and ischemic stroke patients were 0.95(0.11) and 5.57 (0.20) ng/mL respectively (p<0.001). After adjusting for confounders such as total leucocytes count, waist hip ratio, hypertension and smoking mean (SE) were 1.38 (1.23) and 5.26 (0.85) ng/ml respectively (p<0.001). Conclusions: Patients with ischemic stroke have raised level of CEA. CEA is a promising novel biomarker for diagnosis of acute ischemic stroke.
Carcinoembryonic Antigen ; Stroke

No abstract available.
Breast* ; Carcinoembryonic Antigen* ; Humans ; Stomach*

No abstract available.
Carcinoembryonic Antigen* ; Colon* ; Exons* ; Humans*

Carcinoembryonic Antigen ; analysis ; Humans ; Luminescence

No abstract available.
Carcinoembryonic Antigen* ; Colorectal Neoplasms* ; Humans

Participants were 28 healthy people involved in genders, included smokers and non-smokers with age ranged from 18 to 50 years. Standard curve was established using 6 prepared sample kits of manufacturer with levels of 0, 4, 20, 80, 140 and 200ng/ml. The findings suggested that for technical standard, CEA quantification with IRMA using kits of France-based CIS Bio International was reliable, quality of kits and qualification skill is good. Average level of CEA maker in 28 subjects above is 4.19+/-2.35ng/ml with mean-point of 4.48, ranged from 0.00 to 8.37ng/ml. The most common level is 6.37ng/ml. Upper-marginal level is 2.59ng/ml and under-marginal level is 3.36ng/ml. There was insignificant difference between male and female.
Administrative Personnel ; Carcinoembryonic Antigen ; Immunoradiometric Assay ; neoplasms